Ondansetron and Intermediates
|
|
Product Ondansetron and Intermediates
CAS NO 99614-02-5
Standard CP
Molecular Formula C18H20ClN3O
Molecular Weight 329.82
Description off-White or white crystal or crystalline powder
Package 25KG/drums
Application Anti-vomit
,Ondansetron and Intermediates , Ondansetron and Intermediates CAS NO 99614-02-5 |
| |
Racecadotril and Intermediates
|
|
Product Racecadotril and Intermediates
CAS NO 81110-73-8
Standard JP
Molecular Formula C21H23NO4S
Molecular Weight 385.48
Description white crystal or crystalline powder
Package 25KG/drums
Application Fight diarrhea medicine
,Racecadotril and Intermediates , Racecadotril and Intermediates CAS NO 81110-73-8 |
| |
Mefenamic Acid
|
|
Mefenamic Acid
Introduction:
Mefenamic acid is an anti-inflammatory agent that prevents the body from producing prostaglandins, which have been suggested as a cause of PMS. By reducing the amount of prostaglandins in the body, the doctor hopes to eliminate many of the inflammatory symptoms of PMS such as breast pain, headache, swelling, and other discomforts. Mefenamic acid may also be used in the treatment of pelvic pain.
Non-proprietory or generic name Mefenamic Acid
Nomenclature N-(2,3-Dimethylphenyl) anthranilic acid
CAS No. 61-68-7
EINECS No. 200-513-1
Molecular formula C15H15NO2 Molecular weight: 241.29
Chemical constitution
Quality Specification:
Complies with BP,EP, USP
Packaging:
25 kg per fiber drum
20 kg per fiber drum
,Mefenamic Acid , Mefenamic Acid CAS No. 61-68-7 |
| |
Ramosetron HCL and Intermediates
|
|
Product Ramosetron HCL and Intermediates
CAS NO 132907-72-3
Standard CP
Molecular Formula C17H18ClN3O
Molecular Weight 315.8
Description off-White or white crystal or crystalline powder
Package 25KG/drums
Application Anti-vomit
,Ramosetron HCL and Intermediates, Ramosetron HCL and Intermediates CAS NO 132907-72-3 |
| |
Adiphenine hydrochloride
|
|
Product Adiphenine hydrochloride
CAS NO 50-42-0
Standard Enterprise
Molecular Formula C20H25NO2.ClH
Molecular Weight 347.88
Description white crystal or crystalline powder
Package 25KG/drums
Application Treatment stomach cramps
,Adiphenine hydrochloride, Adiphenine hydrochloride CAS NO 50-42-0 |
| |
SECNIDAZOLE and Intermediates
|
|
Product SECNIDAZOLE and Intermediates
CAS NO 3366-95-8
Standard BP USP
Molecular Formula C7H11N3O3
Molecular Weight 185.18
Description off-White crystal or crystalline powder
Package 25KG/drums
Application Antifungal
,SECNIDAZOLE and Intermediates , SECNIDAZOLE and Intermediates CAS NO 3366-95-8 |
| |
Metadoxine and Intermediates
|
|
Product Metadoxine and Intermediates
CAS NO 74536-44-0
Standard Enterprise Standard
Molecular Formula C8H11NO3.C5H7NO3
Molecular Weight 298.293
Description off-White or white crystal or crystalline powder
Package 25KG/drums
Application auxiliary medicine for Liver
,Metadoxine and Intermediates , Metadoxine and Intermediates CAS NO 74536-44-0 |
| |
D-Cycloserine and Intermediates
|
|
Product D-Cycloserine and Intermediates
CAS NO 68-41-7
Standard Enterprise Standard
Molecular Formula C3H6N2O2
Molecular Weight 102.09
Description off-White or white crystal or crystalline powder
Package 25KG/drums
Application tuberculosis
, D-Cycloserine and Intermediates , D-Cycloserine and Intermediates CAS NO 68-41-7 |
| |
Alibendol and Intermediates
|
|
Product Alibendol and Intermediates
CAS NO 26750-81-2
Standard Enterprise Standard
Molecular Formula C13H17NO4
Molecular Weight 251.28
Description off-White or white crystal or crystalline powder
Package 25KG/drums
Application Digestive system
,Alibendol and Intermediates , Alibendol and Intermediates CAS NO 26750-81-2 |
| |
7-ACP
|
|
7-ACP
CAS:197897-11-3
intermediates of cefozopran
,7-ACP, 7-ACP ,CAS:197897-11-3 |
| |
Silodosin and Intermediates
|
|
Product Silodosin and Intermediates
CAS NO 160970-54-7
Standard Enterprise Standard
Molecular Formula C25H32F3N3O4
Molecular Weight 495.53
Description off-White or white crystal or crystalline powder
Package 25KG/drums
Application Urinary system
, Silodosin and Intermediates , Silodosin and Intermediates CAS NO 160970-54-7 |
| |
| |